HK1097438A1 - Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases - Google Patents
Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseasesInfo
- Publication number
- HK1097438A1 HK1097438A1 HK07102495.9A HK07102495A HK1097438A1 HK 1097438 A1 HK1097438 A1 HK 1097438A1 HK 07102495 A HK07102495 A HK 07102495A HK 1097438 A1 HK1097438 A1 HK 1097438A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- neurodegenerative diseases
- acid halide
- hydroximic acid
- halide derivative
- Prior art date
Links
- 230000004770 neurodegeneration Effects 0.000 title abstract 2
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000004820 halides Chemical class 0.000 title 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
- SGEIEGAXKLMUIZ-PEZBUJJGSA-N (3z)-n-(2-hydroxy-3-piperidin-1-ylpropoxy)-1-oxidopyridin-1-ium-3-carboximidoyl chloride Chemical compound C1CCCCN1CC(O)CO\N=C(/Cl)C1=CC=C[N+]([O-])=C1 SGEIEGAXKLMUIZ-PEZBUJJGSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0303584A HUP0303584A3 (en) | 2003-10-30 | 2003-10-30 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
| PCT/HU2004/000098 WO2005041965A1 (en) | 2003-10-30 | 2004-10-25 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1097438A1 true HK1097438A1 (en) | 2007-06-29 |
Family
ID=89981738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK07102495.9A HK1097438A1 (en) | 2003-10-30 | 2007-03-06 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US20080039497A1 (pl) |
| EP (2) | EP2020233A3 (pl) |
| JP (1) | JP5077997B2 (pl) |
| KR (1) | KR20060103323A (pl) |
| CN (1) | CN1901913A (pl) |
| AT (1) | ATE409038T1 (pl) |
| AU (1) | AU2004285343B2 (pl) |
| BR (1) | BRPI0415625A (pl) |
| CA (1) | CA2544332C (pl) |
| CY (1) | CY1110450T1 (pl) |
| CZ (1) | CZ2006347A3 (pl) |
| DE (1) | DE602004016770D1 (pl) |
| DK (1) | DK1696922T3 (pl) |
| EA (1) | EA011301B1 (pl) |
| ES (1) | ES2314458T3 (pl) |
| HK (1) | HK1097438A1 (pl) |
| HR (1) | HRP20080660T3 (pl) |
| HU (1) | HUP0303584A3 (pl) |
| IL (1) | IL175334A (pl) |
| NO (1) | NO20062401L (pl) |
| NZ (1) | NZ547216A (pl) |
| PL (1) | PL1696922T3 (pl) |
| PT (1) | PT1696922E (pl) |
| SI (1) | SI1696922T1 (pl) |
| UA (1) | UA86782C2 (pl) |
| WO (1) | WO2005041965A1 (pl) |
| ZA (1) | ZA200604376B (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7384936B2 (en) | 2002-01-11 | 2008-06-10 | Cytrx Corporation | Carboxamidine derivatives and their use in the treatment of vascular diseases |
| TW200831479A (en) * | 2006-09-26 | 2008-08-01 | Cytrx Corp | Pharmaceutical compositions and methods for treating diseases |
| ES2963910T3 (es) | 2008-06-26 | 2024-04-03 | Zevra Denmark As | Uso de Hsp70 como regulador de la actividad enzimática |
| KR20110084514A (ko) | 2008-11-18 | 2011-07-25 | 산텐 세이야꾸 가부시키가이샤 | 피리딘-3-카르발데히드 ｏ-(피페리딘-1-일-프로필)-옥심 유도체를 유효 성분으로서 함유하는 망맥락막 변성 질환의 치료제 |
| EP2646044B1 (en) | 2010-11-30 | 2019-08-28 | Orphazyme A/S | Methods for increasing intracellular activity of hsp70 |
| HUP1100534A2 (en) * | 2011-09-26 | 2013-04-29 | Balazs Dr Hazay | Pharmaceutical composition for the treatment of muscle atrophy |
| CN103804309B (zh) * | 2012-11-09 | 2019-08-02 | 广州喜鹊医药有限公司 | 一种氯肟类化合物及其制备方法和在制药中的应用 |
| AU2015317447B2 (en) * | 2014-09-15 | 2021-02-25 | Zevra Denmark A/S | Arimoclomol formulation |
| US10898476B2 (en) | 2016-04-13 | 2021-01-26 | Orphazyme A/S | Heat shock proteins and cholesterol homeostasis |
| HUE052158T2 (hu) * | 2016-04-29 | 2021-04-28 | Orphazyme As | Arimoklomol a glükocerebroszidázzal társult rendellenességek kezeléséhez |
| BR112019024667A2 (pt) | 2017-05-24 | 2020-06-16 | Orphazyme A/S | Uso de um agente bioativo, e, de uma composição |
| HUP1800298A1 (hu) | 2018-08-30 | 2020-05-28 | N Gene Res Laboratories Inc | Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére |
| JP2024500632A (ja) | 2020-11-19 | 2024-01-10 | ゼブラ デンマーク エー／エス | アリモクロモルクエン酸塩及びその中間体の調製プロセス |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU177578B (en) | 1976-08-27 | 1981-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives |
| DE2651083A1 (de) | 1976-11-09 | 1978-05-18 | Hoechst Ag | Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung |
| HU207988B (en) * | 1988-10-20 | 1993-07-28 | Biorex Kutato Fejlesztoe Kft | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
| HUT54347A (en) * | 1989-01-10 | 1991-02-28 | Chinoin Gyogyszer Es Vegyeszet | Improved process for producing amidoximes |
| US5334600A (en) * | 1991-07-30 | 1994-08-02 | Ciba-Geigy Corporation | Isoquinolyl substituted hydroxylamine derivatives |
| NZ285151A (en) | 1994-05-06 | 1998-09-24 | Biorex Kutato Fejlesztoe Kft | Hydroximic acid derivatives |
| HU9502843D0 (en) * | 1995-09-29 | 1995-11-28 | Livigene Ltd | Pharmaceutical composition |
| HU222994B1 (hu) * | 1995-11-02 | 2004-01-28 | BIOREX Kutató és Fejlesztő Rt. | Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására |
| UA64716C2 (en) | 1996-08-09 | 2004-03-15 | Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells | |
| HU220971B1 (hu) | 1997-04-03 | 2002-07-29 | BIOREX Kutató és Fejlesztő Rt. | Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására |
| UA65635C2 (uk) * | 1998-09-03 | 2004-04-15 | Н-Гене Кутато Кфт. | НЕНАСИЧЕНІ ПОХІДНІ ГІДРОКСИМОВОЇ КИСЛОТИ, ЩО МАЮТЬ ВЛАСТИВОСТІ ІНГІБІТОРІВ NAD<sup>+</sup>-ADP-РИБОЗИЛТРАНСФЕРАЗИ |
| HUP9900475D0 (en) * | 1999-02-26 | 1999-04-28 | Biorex Kutato Fejlesztoe Kft | O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component |
| HUP0001583A2 (hu) | 2000-04-18 | 2002-11-28 | BIOREX Kutató és Fejlesztő Rt. | Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké |
| HU0103939D0 (en) * | 2001-09-27 | 2001-11-28 | Biorex Kutato Fejlesztoe Kft | Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride |
| ITMI20012573A1 (it) | 2001-12-06 | 2003-06-06 | D B P Dev Biotechonologica L P | Gli acilsalicilati:una nuova classe di induttori di risposta heat shock |
-
2003
- 2003-10-30 HU HU0303584A patent/HUP0303584A3/hu unknown
-
2004
- 2004-10-25 DK DK04791657T patent/DK1696922T3/da active
- 2004-10-25 EA EA200600866A patent/EA011301B1/ru not_active IP Right Cessation
- 2004-10-25 UA UAA200605899A patent/UA86782C2/ru unknown
- 2004-10-25 US US10/582,124 patent/US20080039497A1/en not_active Abandoned
- 2004-10-25 EP EP08157425A patent/EP2020233A3/en not_active Withdrawn
- 2004-10-25 SI SI200430887T patent/SI1696922T1/sl unknown
- 2004-10-25 PT PT04791657T patent/PT1696922E/pt unknown
- 2004-10-25 KR KR1020067010489A patent/KR20060103323A/ko not_active Application Discontinuation
- 2004-10-25 WO PCT/HU2004/000098 patent/WO2005041965A1/en active IP Right Grant
- 2004-10-25 ZA ZA200604376A patent/ZA200604376B/xx unknown
- 2004-10-25 BR BRPI0415625-0A patent/BRPI0415625A/pt not_active Application Discontinuation
- 2004-10-25 AT AT04791657T patent/ATE409038T1/de active
- 2004-10-25 NZ NZ547216A patent/NZ547216A/en unknown
- 2004-10-25 ES ES04791657T patent/ES2314458T3/es active Active
- 2004-10-25 CZ CZ20060347A patent/CZ2006347A3/cs unknown
- 2004-10-25 DE DE602004016770T patent/DE602004016770D1/de active Active
- 2004-10-25 CN CNA2004800396198A patent/CN1901913A/zh active Pending
- 2004-10-25 PL PL04791657T patent/PL1696922T3/pl unknown
- 2004-10-25 EP EP04791657A patent/EP1696922B1/en active Active
- 2004-10-25 AU AU2004285343A patent/AU2004285343B2/en not_active Ceased
- 2004-10-25 CA CA2544332A patent/CA2544332C/en not_active Expired - Fee Related
- 2004-10-25 JP JP2006537449A patent/JP5077997B2/ja not_active Expired - Fee Related
-
2006
- 2006-04-30 IL IL175334A patent/IL175334A/en not_active IP Right Cessation
- 2006-05-26 NO NO20062401A patent/NO20062401L/no not_active Application Discontinuation
-
2007
- 2007-03-06 HK HK07102495.9A patent/HK1097438A1/xx not_active IP Right Cessation
-
2008
- 2008-12-10 CY CY20081101426T patent/CY1110450T1/el unknown
- 2008-12-19 HR HR20080660T patent/HRP20080660T3/xx unknown
-
2011
- 2011-09-12 US US13/229,862 patent/US8962604B2/en not_active Expired - Fee Related
-
2015
- 2015-01-12 US US14/594,817 patent/US20150126551A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1097438A1 (en) | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases | |
| SE0104340D0 (sv) | New compounds | |
| NO20093464L (no) | Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika | |
| HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
| TW200606164A (en) | New compounds | |
| MY135218A (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases | |
| TW200531688A (en) | Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents | |
| ATE367387T1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden | |
| SE9901573D0 (sv) | New compounds | |
| SE0102440D0 (sv) | New compound | |
| IL152337A0 (en) | A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds | |
| HRP20050831A2 (en) | Novel oxazole derivatives, their manufacture and use as pharmaceutical agents | |
| SE9901572D0 (sv) | New compounds | |
| SE9900190D0 (sv) | New compounds | |
| SE0203778D0 (sv) | A new oral immediated release dosage form | |
| MXPA05011671A (es) | Nuevos derivados de anilina, su manufactura y su uso como agentes farmaceuticos. | |
| TW200626591A (en) | Amide derivatives, their manufacture and use as pharmaceutical agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20121025 |